The quality of YouTube videos on radiotherapy and prostatectomy for prostate cancer
DOI:
https://doi.org/10.5489/cuaj.8523Keywords:
YouTube, Radiotherapy, Prostatectomy, prostate cancerAbstract
INTRODUCTION: Prostate cancer ranks as the third leading cause of death among Canadian men and is primarily treated with radiotherapy and prostatectomy. Given YouTube’s significant global traffic, patients often turn to it for information on treatment and side effects. This study assessed YouTube videos for prostate cancer patients, focusing on radiotherapy, prostatectomy, and side effect management.
METHODS: The study analyzed 50 YouTube videos, comparing their accuracy and coverage against the National Comprehensive Cancer Network (NCCN), UpToDate, and cancer.ca. Two raters were involved in the review of the videos to ensure inter-rater reliability.
RESULTS: Video lengths ranged from 1–60 minutes (mean 11 minutes) and creation dates ranged from 2012–2021. Videos were presented by physicians, patients, or allied health professionals (75%, 16%, and 8%, respectively). Results showed physician presenters had a Video Power Index (video popularity) of 23.45, while patient presenters had an average of 61.36 (almost three times as popular as physician-led videos). The overall accuracy of videos showed that 82% demonstrated completely accurate and detailed information, 18% showed partially complete information, and 76% showed no biased information. No false information was found in any videos.
CONCLUSIONS: This study showed that while the YouTube informational videos included good coverage of treatment side effects, there were gaps in information regarding quality of life after treatment or management of side effects. Information from this study can benefit the provider-patient interaction, with the hope that healthcare providers create more videos on quality of life after treatment and management of side effects to satisfy patient needs.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
You, the Author(s), assign your copyright in and to the Article to the Canadian Urological Association. This means that you may not, without the prior written permission of the CUA:
- Post the Article on any Web site
- Translate or authorize a translation of the Article
- Copy or otherwise reproduce the Article, in any format, beyond what is permitted under Canadian copyright law, or authorize others to do so
- Copy or otherwise reproduce portions of the Article, including tables and figures, beyond what is permitted under Canadian copyright law, or authorize others to do so.
The CUA encourages use for non-commercial educational purposes and will not unreasonably deny any such permission request.
You retain your moral rights in and to the Article. This means that the CUA may not assert its copyright in such a way that would negatively reflect on your reputation or your right to be associated with the Article.
The CUA also requires you to warrant the following:
- That you are the Author(s) and sole owner(s), that the Article is original and unpublished and that you have not previously assigned copyright or granted a licence to any other third party;
- That all individuals who have made a substantive contribution to the article are acknowledged;
- That the Article does not infringe any proprietary right of any third party and that you have received the permissions necessary to include the work of others in the Article; and
- That the Article does not libel or violate the privacy rights of any third party.